Noxopharm
Australian publicly-listed clinical stage drug development company discovering and developing novel treatments for cancer and inflammation.v.
Market cap
$18.9m
Enterprise value
$16m
Share price
AUD0.11 NOX.AX
Company register number
50 608 966 123
Authorizing premium user...